Ask AI
1801 Part 3B Ph II of Elraglusib
1801 Part 3B: Preliminary Results From a Phase II Study of Elraglusib + Gemcitabine/nab-Paclitaxel (GnP) vs GnP in Previously Untreated mPDAC

Released: June 11, 2025

Expiration: December 10, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 11, 2025

Expiration: December 10, 2025